1. Lawson DM, Sensui N, Haisenleder DH, Kaufman PN, Gala RR: Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors. Breast Cancer Res Treat 4: 129–136, 1984
2. Nicholson RI, Walker KJ, Davies P: Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer. Cancer Surv 5: 463–486, 1986
3. Bruning PF: Prolactin and breast cancer. In: Klijn JGM, Paridaens R, Foekens JA (eds) Hormonal Manipulation of Cancer: Peptides, Growth Factors and New (Anti)steroidal Agents. EORTC Monograph Series, Raven Press, New York, vol 18: 167–173, 1987
4. L'Hermite-Balériaux M, Casteels S, L'Hermite M: Prolactin receptors in breast cancer: importance of the membrane preparation: In: Klijn JGM, Paridaens R, Foekens JA (eds) Hormonal Manipulation of Cancer: Peptides, Growth Factors and New (Anti)steroidal Agents. EORTC Monograph Series, Raven Press, New York, vol 18: 157–165, 1987
5. Peyrat JP, Djiane J, Kelly PA, Vandewalle B, Bonneterre J, Demaille A: Characterization of prolactin receptors in human breast cancer. Breast Cancer Res Treat 4: 275–281, 1984